StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AXIM Biotechnologies's price to sales ratio was 9.7× on Oct 19, 2026, against 31.7× a year earlier. Over the last 5 years it ranged from 6.0× to 498.7×, with a median of 45.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20269.7×−24.2
2025Dec 31, 202533.9×+27.9
2024Dec 31, 20246.0×−125.0
2023Dec 29, 2023131.0×−86.9
2022Jul 29, 2022217.9×+152.1
2021Jan 29, 202165.8×−2.0
2020Dec 31, 202067.8×−56.7
2019Dec 31, 2019124.5×−29.9
2016Sep 30, 2016154.4×−195.8
2015Dec 31, 2015350.2×–

More AXIM Biotechnologies figures

See a number that looks wrong?